How I treat heparin-induced thrombocytopenia and thrombosis

This publication has 40 references indexed in Scilit:

• Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin‐induced thrombocytopenia
  Catheterization and Cardiovascular Interventions, 2002
• Lepirudin as a safe alternative for effective anticoagulation in patients with known heparin‐induced thrombocytopenia undergoing percutaneous coronary intervention: Case reports
  Catheterization and Cardiovascular Interventions, 2001
• A quick assay for monitoring recombinant hirudin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type IIAdaptation of the ecarin clotting time to the Act II device
  The Journal of Thoracic and Cardiovascular Surgery, 2000
• Prevalence of Heparin-Associated Antibodies Without Thrombosis in Patients Undergoing Cardiopulmonary Bypass Surgery
  Circulation, 1997
• A 14-year study of heparin-induced thrombocytopenia
  The American Journal of Medicine, 1996
• Comparing Subcutaneous Danaparoid with Intravenous Unfractionated Heparin for the Treatment of Venous Thromboembolism
  Annals of Internal Medicine, 1995
• Recombinant hirudin: A specific thrombin inhibiting anticoagulant for hemodialysis
  Kidney International, 1994
• TREATMENT OF HEPARIN‐INDUCED THROMBOCYTOPENIA BY USE OF ARGATROBAN, A SYNTHETIC THROMBIN INHIBITOR
  British Journal of Haematology, 1992
• A Strategy for a Rational Approach to Designing Synthetic Selective Inhibitors
  Seminars in Thrombosis and Hemostasis, 1992
• Pharmacokinetic Considerations on Orgaran (Org 10172) Therapy
  Pathophysiology of Haemostasis and Thrombosis, 1992